{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:00:49Z","timestamp":1791414049094,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771364"],"award-info":[{"award-number":["81771364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10072-021-05599-z","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T11:04:59Z","timestamp":1634900699000},"page":"2775-2783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characteristics of myasthenia gravis in elderly patients: a retrospective study"],"prefix":"10.1007","volume":"43","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-0338","authenticated-orcid":false,"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"issue":"5","key":"5599_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/WCO.0b013e3283572588","volume":"25","author":"NE Gilhus","year":"2012","unstructured":"Gilhus NE (2012) Myasthenia and the neuromuscular junction. Curr Opin Neurol 25(5):523\u2013529","journal-title":"Curr Opin Neurol"},{"issue":"1\u20132","key":"5599_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cccn.2004.05.008","volume":"348","author":"I Matthews","year":"2004","unstructured":"Matthews I, Chen S, Hewer R, McGrath V, Furmaniak J, Rees SB (2004) Muscle-specific receptor tyrosine kinase autoantibodies\u2013a new immunoprecipitation assay. Clin Chim Acta 348(1\u20132):95\u201399","journal-title":"Clin Chim Acta"},{"key":"5599_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","volume":"52","author":"P Zisimopoulou","year":"2014","unstructured":"Zisimopoulou P, Evangelakou P, Tzartos J et al (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139\u2013145","journal-title":"J Autoimmun"},{"issue":"5","key":"5599_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/WCO.0b013e328364c079","volume":"26","author":"L Querol","year":"2013","unstructured":"Querol L, Illa I (2013) Myasthenia gravis and the neuromuscular junction. Curr Opin Neurol 26(5):459\u2013465","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"5599_CR5","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1468-1331.2010.03089.x","volume":"17","author":"JB Andersen","year":"2010","unstructured":"Andersen JB, Engeland A, Owe JF, Gilhus NE (2010) Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. Eur J Neurol 17(12):1445\u20131450","journal-title":"Eur J Neurol"},{"key":"5599_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J (2010) A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol 10:46","journal-title":"BMC Neurol"},{"issue":"2","key":"5599_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1212\/WNL.0b013e3181ad53c2","volume":"73","author":"AT Heldal","year":"2009","unstructured":"Heldal AT, Owe JF, Gilhus NE, Romi F (2009) Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology 73(2):150\u2013151","journal-title":"Neurology"},{"issue":"17","key":"5599_CR8","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1212\/WNL.0b013e318217e735","volume":"76","author":"Z Pakzad","year":"2011","unstructured":"Pakzad Z, Aziz T, Oger J (2011) Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada. Neurology 76(17):1526\u20131528","journal-title":"Neurology"},{"issue":"6","key":"5599_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000080093","volume":"23","author":"I Casetta","year":"2004","unstructured":"Casetta I, Fallica E, Govoni V, Azzini C, Tola M, Granieri E (2004) Incidence of myasthenia gravis in the province of Ferrara: a community-based study. Neuroepidemiology 23(6):281\u2013284","journal-title":"Neuroepidemiology"},{"issue":"6","key":"5599_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2169\/internalmedicine.44.572","volume":"44","author":"M Matsuda","year":"2005","unstructured":"Matsuda M, Dohi-Iijima N, Nakamura A et al (2005) Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med 44(6):572\u2013577","journal-title":"Intern Med"},{"issue":"3","key":"5599_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/jnnp.71.3.352","volume":"71","author":"K Poulas","year":"2001","unstructured":"Poulas K, Tsibri E, Kokla A et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 71(3):352\u2013356","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"5599_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 65(6):928\u2013930","journal-title":"Neurology"},{"key":"5599_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1196\/annals.1405.040","volume":"1132","author":"JA Aarli","year":"2008","unstructured":"Aarli JA (2008) Myasthenia gravis in the elderly: is it different. Ann N Y Acad Sci 1132:238\u2013243","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"5599_CR14","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/j.1532-5415.2000.tb02635.x","volume":"48","author":"A Evoli","year":"2000","unstructured":"Evoli A, Batocchi AP, Minisci C, Di SC, Tonali P (2000) Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc 48(11):1442\u20131448","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"5599_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M et al (2016) International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87(4):419\u2013425","journal-title":"Neurology"},{"issue":"1","key":"5599_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/01616412.2018.1525121","volume":"41","author":"L Fan","year":"2019","unstructured":"Fan L, Ma S, Yang Y, Yan Z, Li J, Li Z (2019) Clinical differences of early and late-onset myasthenia gravis in 985 patients. Neurol Res 41(1):45\u201351","journal-title":"Neurol Res"},{"key":"5599_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1749-6632.1998.tb11017.x","volume":"841","author":"G Slesak","year":"1998","unstructured":"Slesak G, Melms A, Gerneth F, Sommer N, Weissert R, Dichgans J (1998) Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60. Ann N Y Acad Sci 841:777\u201380","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"5599_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","volume":"305","author":"H Murai","year":"2011","unstructured":"Murai H, Yamashita N, Watanabe M et al (2011) Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci 305(1\u20132):97\u2013102","journal-title":"J Neurol Sci"},{"issue":"5","key":"5599_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/mus.23964","volume":"48","author":"NM Alkhawajah","year":"2013","unstructured":"Alkhawajah NM, Oger J (2013) Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing. Muscle Nerve 48(5):705\u2013710","journal-title":"Muscle Nerve"},{"issue":"5","key":"5599_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1212\/WNL.40.5.786","volume":"40","author":"DH Donaldson","year":"1990","unstructured":"Donaldson DH, Ansher M, Horan S, Rutherford RB, Ringel SP (1990) The relationship of age to outcome in myasthenia gravis. Neurology 40(5):786\u2013790","journal-title":"Neurology"},{"key":"5599_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ensci.2016.02.004","volume":"2","author":"W Sakai","year":"2016","unstructured":"Sakai W, Matsui N, Ishida M et al (2016) Late-onset myasthenia gravis is predisposed to become generalized in the elderly. eNeurologicalSci 2:17\u201320","journal-title":"eNeurologicalSci"},{"issue":"1","key":"5599_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000116785","volume":"32","author":"A Evoli","year":"1992","unstructured":"Evoli A, Batocchi AP, Palmisani MT, Lo MM, Tonali P (1992) Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur Neurol 32(1):37\u201343","journal-title":"Eur Neurol"},{"issue":"5","key":"5599_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2165\/00003495-199652050-00004","volume":"52","author":"A Evoli","year":"1996","unstructured":"Evoli A, Batocchi AP, Tonali P (1996) A practical guide to the recognition and management of myasthenia gravis. Drugs 52(5):662\u2013670","journal-title":"Drugs"},{"key":"5599_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1749-6632.1987.tb51327.x","volume":"505","author":"G Matell","year":"1987","unstructured":"Matell G (1987) Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis. Ann N Y Acad Sci 505:589\u2013594","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"5599_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s00415-017-8616-7","volume":"264","author":"L Wang","year":"2017","unstructured":"Wang L, Zhang S, Xi J et al (2017) Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis. J Neurol 264(11):2191\u20132200","journal-title":"J Neurol"},{"issue":"6","key":"5599_CR26","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","volume":"50","author":"J Palace","year":"1998","unstructured":"Palace J, Newsom-Davis J, Lecky B (1998) A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology 50(6):1778\u20131783","journal-title":"Neurology"},{"issue":"3","key":"5599_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/205873929901200303","volume":"12","author":"K Kapinas","year":"1999","unstructured":"Kapinas K, Kimiskidis VK, Kazis AD, Kokkas B, Tsolaki M, Georgiadis G (1999) Myasthenia gravis: correlation of age with clinical course and anti-AChr antibody levels. Int J Immunopathol Pharmacol 12(3):127\u2013131","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"5599_CR28","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S0003-4975(99)00167-8","volume":"67","author":"M Tsuchida","year":"1999","unstructured":"Tsuchida M, Yamato Y, Souma T et al (1999) Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis. Ann Thorac Surg 67(6):1563\u20131567","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"5599_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.clineuro.2007.05.023","volume":"109","author":"KH Chan","year":"2007","unstructured":"Chan KH, Cheung RT, Mak W, Ho SL (2007) Nonthymoma early-onset- and late-onset-generalized myasthenia gravis\u2013a retrospective hospital-based study. Clin Neurol Neurosurg 109(8):686\u2013691","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05599-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05599-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T07:12:02Z","timestamp":1647069122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05599-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5599"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05599-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"22 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Xiangya Hospital, Central South University. All participants were informed and signed the consent form for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}